chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Vomiting
Clinical narrative: Chills; Severe headache; Fatigue; Vomiting 2x; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 27Mar2021 at 08:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 08:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included statin (MANUFACTURER UNKNOWN) and escitalopram oxalate (LEXAPRO). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 19:30, the patient experienced chills, severe headache, fatigue, nausea and vomiting 2x. Lasted about 36 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was taken for the reported events. The clinical outcome of the events chills, severe headache, fatigue, nausea and vomiting was resolved on an unspecified date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Nausea
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 29Mar2021 at 11:45 (at the age of 54-years-old) as a single dose for COVID-19 immunization. Medical history included hay fever. Concomitant medication included mometasone furoate (FLONASE) taken for unknown indication. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 08Mar2021 13:45 PM. Prior to vaccination, patient was not diagnosed with COVID-19 and not tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient experienced soreness at injection site, headache and mild nausea. Therapeutic measures taken were acetaminophen 500mg for the events. The clinical outcome of the events injection site pain, headache and nausea was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Lip swelling, Vaccination site pain
Clinical narrative: lip swelling after 3 hours of vaccination; arm pain on the vaccination location; This is a spontaneous report from a non-contactable healthcare professional. A patient of unknown age and gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 17:15 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 19:00 the patient experienced lip swelling after 3 hours of vaccination and had arm pain on the vaccination location. Therapeutic measures were taken as a result of the event arm pain on the vaccination location and included treatment with tylenol but the arm pain did not get better. The clinical outcome of the events arm pain on the vaccination location and lip swelling were not resolved at the time of the report.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Depression, Fatigue
Clinical narrative: Fatigue; Depression; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730), via an unspecified route of administration on an unknown date (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient experienced fatigue and depression. The patient did not receive any treatment for the events fatigue and depression. The clinical outcomes of the events fatigue and depression were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Flushing, Headache, Nausea
Clinical narrative: (MANUFACTURER UNKNOWN) in the past and experienced vaccine allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID -19 vaccine. On 20Mar2021, the patient experienced facial flushing, fatigue, dizziness, mild headaches and nausea with dizziness. No therapeutic measures were taken as the result of adverse events. The adverse event resulted in visit to the doctors or other healthcare professional office/clinic visit. The clinical outcomes of the events facial flushing, fatigue, dizziness, mild headaches and nausea with dizziness were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Neck mass, Pain, Tenderness
Clinical narrative: Swollen lymph mode; Tender; Sudden mass (ganglion?) above left collar bone; Sore; This is a spontaneous report from a contactable consumer, the patient. A 41-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 27Mar2021 at 11:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included anemia. The patient had no known allergies to medications, food, or other products were reported. Concomitant medications included VIT D3 (MANUFACTURER UNKNOWN) 50000 IU one per week, from unknown date for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 17:00 the patient experienced swollen lymph node, neck mass, sudden mass (ganglion) above left collar bone, sore and tenderness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the swollen lymph node, neck mass, sore and tenderness was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort
Clinical narrative: Ears feel clogged, like the sensation on an airplane (both ears); This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm right on 10Mar2021 at 15:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer in 2012. The patient previously received penicillin and erythromycin and experienced allergy. Concomitant medications included tamoxifen citrate (TAMOXIFEN) and escitalopram (MANUFACTURER UNKNOWN) from an unknown date and for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 20Mar2021, the patient experienced ears feel clogged, like the sensation on an airplane (both ears). The patient did not receive any treatment for the event. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event ears feel clogged was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: Fever, body aches, headache lasting ~1 day; Fever; Body aches; This is a spontaneous report from a non-contactable pharmacist. A 29-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3247) via an unspecified route of administration on 29Mar2021 at 13:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant therapy were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications  within 2 weeks of vaccination. The patient had no reported allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 29Mar2021 the patient experienced fever, body aches, headache. It was mentioned that the events last less than a day. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever, body aches, headache was resolved on an unknown date.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 28Mar2021 at 04:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had a medical history of COVID-19. The patient did not have any allergies to medications, food, or other products. The patient did not take any other medications in two weeks of the vaccination.  Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, it is unknown if the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021, the patient experienced tiredness. The patient did not receive any treatment for the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tiredness was not resolved.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blepharospasm, Body temperature, Limb discomfort, Muscle twitching
Clinical narrative: This is a spontaneous report from a contactable consumer. A 35-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm left on 13Mar2021 at 17:15 (at the age of 35-years-old) as a single dose for COVID-19 immunization. Medical history included mitral valve prolapse and COVID-19. The patient was not allergic to food, medication or other product. The patient had no concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021, the patient experienced immediate shoulder discomfort. On 14Mar2021 at 01:15 (8 hours later), The patient's arm felt like it was broken and unable to lift away from body without excruciating pain. On 14Mar2021, the patient developed a 102 fever (units unspecified). On 14Mar2021 (24-32 hours later), the patient experienced severe arm pain subsided and shoulder joint pain when lifting above her head and to the right alongside dull aches when resting. On 14Mar2021, the patient underwent test for body temperature and the result was 102 (unspecified units). On 15Mar2021 (on Monday), the patient's left upper eyelid began twitching persistently and through the day. The patient also experienced twitches in legs, and elbows on both sides more so on left and arch of foot. The patient did not receive any treatment for the event. On 08Dec2020, the patient underwent COVID-19 virus test and the result was found to be positive. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event shoulder discomfort, arm felt like it was broke, severe arm pain and unable to lift away from body without excruciating pain, fever (102), joint pain in the shoulder of injection and shoulder joint pain, left upper eyelid twitching and twitches (legs, elbows on both sides on left and arch of foot) were not resolved at the time of this reports. No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Pain in extremity, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: This is a spontaneous report from a contactable consumer. A 35-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm left on 13Mar2021 at 17:15 (at the age of 35-years-old) as a single dose for COVID-19 immunization. Medical history included mitral valve prolapse and COVID-19. The patient was not allergic to food, medication or other product. The patient had no concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021, the patient experienced immediate shoulder discomfort. On 14Mar2021 at 01:15 (8 hours later), The patient's arm felt like it was broken and unable to lift away from body without excruciating pain. On 14Mar2021, the patient developed a 102 fever (units unspecified). On 14Mar2021 (24-32 hours later), the patient experienced severe arm pain subsided and shoulder joint pain when lifting above her head and to the right alongside dull aches when resting. On 14Mar2021, the patient underwent test for body temperature and the result was 102 (unspecified units). On 15Mar2021 (on Monday), the patient's left upper eyelid began twitching persistently and through the day. The patient also experienced twitches in legs, and elbows on both sides more so on left and arch of foot. The patient did not receive any treatment for the event. On 08Dec2020, the patient underwent COVID-19 virus test and the result was found to be positive. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event shoulder discomfort, arm felt like it was broke, severe arm pain and unable to lift away from body without excruciating pain, fever (102), joint pain in the shoulder of injection and shoulder joint pain, left upper eyelid twitching and twitches (legs, elbows on both sides on left and arch of foot) were not resolved at the time of this reports. No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dermatitis, Muscle spasms, Nasal congestion, Nausea
Clinical narrative: chills; fever; itching on bottoms of feet; dyshidrotic dermatitis flare; muscle spasms in all extremities and fingers,but intense in the right leg,; nausea; stuffiness; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via an unspecified route of administration in the left arm on 29Mar2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included dyshidrotic dermatitis, attention deficit hyperactivity disorder and childhood history of kidney issues. The patient had known allergies to numerous antibiotics, codeine, peanuts, walnuts, and pecans. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), from unknown date and for unspecified indication. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Jan2021, at 00:00 the patient experienced chills, fever, itching on bottoms of feet (dyshidrotic dermatitis flare), muscle spasms in all extremities and fingers, but intense in the right leg, stuffiness, and nausea. No therapeutic measures were taken as a result of the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, fever, itching on bottoms of feet (dyshidrotic dermatitis flare), muscle spasms, stuffiness, and nausea were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia
Clinical narrative: chills; fever; itching on bottoms of feet; dyshidrotic dermatitis flare; muscle spasms in all extremities and fingers,but intense in the right leg,; nausea; stuffiness; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via an unspecified route of administration in the left arm on 29Mar2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included dyshidrotic dermatitis, attention deficit hyperactivity disorder and childhood history of kidney issues. The patient had known allergies to numerous antibiotics, codeine, peanuts, walnuts, and pecans. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), from unknown date and for unspecified indication. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Jan2021, at 00:00 the patient experienced chills, fever, itching on bottoms of feet (dyshidrotic dermatitis flare), muscle spasms in all extremities and fingers, but intense in the right leg, stuffiness, and nausea. No therapeutic measures were taken as a result of the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, fever, itching on bottoms of feet (dyshidrotic dermatitis flare), muscle spasms, stuffiness, and nausea were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Overnight soreness in left arm; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734), via an unspecified route of administration in the left arm on 29Mar2021 at 12:15 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 29Mar2021, the patient experienced overnight soreness in left arm. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the overnight soreness in left arm. The clinical outcome of the event overnight soreness in left arm was resolved in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: Ongoing body ache; Chills; Headache; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 29Mar2021 at 10:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. No relevant medical history was reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included daily intake of multivitamins (MANUFACTURER UNKNOWN). The patient had no allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021, the patient experienced body ache, chills, and headache. The patient did not receive any treatment for the adverse events. The events did not result in a doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events body ache, chills, and headache were resolving at the time of this report.   No follow-up attempts are needed. No further information expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Limb discomfort, Pain in extremity, Pyrexia
Clinical narrative: could not move my arm past my head; On Day 2, patient had a fever of 100.2 degrees F; Arm was very sore; This is a spontaneous report from a contactable pharmacist, the patient. A 28-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration on 25Mar2021(at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. Concomitant medications included ethinylestradiol, levonorgestrel (ORSYTHIA) received within 2 weeks of vaccination. The patient had no known allergies to food, medication or other product. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration on 06Mar2021(at the age of 28-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021, the patient experienced sore arm. On 26Mar2021 (day 2), the patient could not move arm past her head, however this resided by day 3. On 26Mar2021 the patient also experienced fever of 100.2 degrees F. Therapeutic measures were taken as a result of adverse events and included treatment with naproxen for fever. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event arm was very sore was recovered on unknown date in Mar2021. The clinical outcome of event could not move arm past head (arm discomfort) was recovered on 27March2021. The clinical outcome of the event fever was recovered on 26March2021.   No follow-up attempts are needed. No further information is expected
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: gout; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6204) via an unspecified route of administration, in the left arm on 18Mar2021 at 12:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease. Concomitant medications included levothyroxine sodium (SYNTHROID), from unknown date and for unspecified indication. The patient previously received Ibuprofen on unknown date and for unspecified indication and patient experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 23Mar2021, approximately five days after receiving the vaccine, the patient experienced gout, which the patient never had in the past. The adverse events resulted in a visit to the doctors or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported events and included treatment with steroids. The clinical outcome of the event gout was recovering.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: chills; fever; fatigue; This is a spontaneous report from a non-contactable consumer. A patient of unspecified age and gender received BNT162B2 (BNT162B2, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications was not reported. After first dose of covid-19 vaccine, experienced chills, fever, and fatigue for approximately 6 hours. Outcome of the events was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Lymphadenopathy, Malaise, Pain
Clinical narrative: Body aches; joint pain; tiredness; injection site soreness; feeling unwell; swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 26Mar2021 at 15:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included RA (rheumatoid arthritis) and blood pressure high. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 05Mar2021 at 10:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 15:00, the patient experienced body aches, joint pain, tiredness, injection site soreness, feeling unwell swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events The clinical outcomes of the events body aches, joint pain, tiredness, injection site soreness, feeling unwell swollen lymph nodes were unknown.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Body aches; joint pain; tiredness; injection site soreness; feeling unwell; swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 26Mar2021 at 15:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included RA (rheumatoid arthritis) and blood pressure high. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 05Mar2021 at 10:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 15:00, the patient experienced body aches, joint pain, tiredness, injection site soreness, feeling unwell swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events The clinical outcomes of the events body aches, joint pain, tiredness, injection site soreness, feeling unwell swollen lymph nodes were unknown.   No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received first dose of BNT162Bb2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 22Mar2021 at 15:00 (at the age of 34-years-old) as a single dose for COVID-19 immunization. Medical history included asthma, penicillin allergy, fruit allergy (peach), pine trees allergy, and dust allergy. The patient did not receive any concomitant medications. Prior to vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, the patient experienced swollen lymph nodes under the left arm, neck and groin. The patient did not receive any treatment for the reported event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph nodes under the left arm, neck, and groin was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Racing heart; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6200) via an unspecified route of administration in the right arm on 24Feb2021 at 10:00 (at the age of 71-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6204) via an unspecified route of administration in the right arm on 17Mar2021 at 11:00 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation, COVID-19 since unknown date and no thyroid. The patient was allergic to lisinopril and tape. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), pravastatin (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN) all for unknown indications from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. The patient had not undergone COVID-19 test. Since the vaccination, the patient was not tested for COVID-19. On 25Mar2021 at 15:00 the patient experienced racing heart, also on day after both the vaccinations. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic. No therapeutic treatment was taken for the reported event. The clinical outcome of the event heart racing was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pain
Clinical narrative: mild body ache; Jointpain; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the arm left on 16Mar2021(at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration on 23Feb2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021 after taking second dose, the patient experienced mild body ache, Joint pain, fatigue. The clinical outcome of the events mild body ache, Joint pain, fatigue were recovered.   No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Paraesthesia
Clinical narrative: Tingling down left arm and feet; pain at elbow joint; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) in the left arm on 26Mar2021 at 09:00, (at the age of 46-year-old) as a single dose for COVID-19 immunisation.  Medical history included autoimmune hashimoto's and hypothyroidism. The patient had known allergies to egg whites and milk. Concomitant medications included levothyroxine sodium (SYNTHROID), vitamin d (MANUFACTURER UNKNOWN) and cetirizine hydrochloride (ZYRTEC). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 19:00, the patient experienced tingling down left arm and feet and pain at elbow joint. No therapeutic measures were taken to treat the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.The clinical outcome of the events tingling down left arm and feet and pain at elbow joint was not recovered, at the time this report.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pain in extremity, Somnolence
Clinical narrative: Full body aches; Sleepy; Pain in arm; Tired; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the arm left on 28Mar2021 at 12:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021 at 16:00, the patient experienced pain in arm, full body aches, tired/sleepy and headache. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events pain in arm, full body aches, tired/sleepy and headache were recovered on an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular, Polymenorrhoea
Clinical narrative: Period started day after first dose (about 2 weeks early); Period happening every other week since vaccination.; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the arm left on 07Feb2021 at 00:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had no physical illness. The patient had an unknown food allergy and had sores on mouth. Concomitant medications included cariprazine hydrochloride (VRAYLAR) taken from unspecified date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Feb2021 at 00:00, the patient had her period started the day after the first dose (reported as about 2 weeks early) and this happened every other week. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events period started day after the first dose(reported as about 2 weeks early) and period happening every other week were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Oxygen saturation, Oxygen saturation decreased
Clinical narrative: heart rate would increase to 110per BP cuff; oxygen woulddecrease to 90% per oximeter.; This is a spontaneous report from a contactable pharmacist. A 73-years-old non-pregnant female patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot Number: EP7534) via intramuscular route of administration in the arm left on 13Mar2021(at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, diabetes and palpitations on an unspecified date. Other medications in two weeks received by patient included metoprolol (MANUFACTURER UNKNOWN), budesonide; formoterol fumarate (SYMBICORT), hydrochlorothiazide (HCTZ), and fluticasone propionate (FLONASE), all taken from an unspecified date for unknown indications. The patient previously took Aspirin and experienced allergy. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination. It was unknown if the patient had been tested for COVID-19, since the vaccination. On 14Mar2021 the patient experienced heart rate increased and oxygen saturation decreased. The patient felt fine at the day of vaccine. Next day if she was sitting, patient felt fine. However, if she stood up and took a few steps her heart rate would increase to 110 per BP cuff and her oxygen would decrease to 90% per oximeter. She continued to feel this way for 2 weeks and suddenly felt better after 2 weeks. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of heart rate high and oxygen saturation decreased which included treatment with albuterol via nebulizer per pt. The clinical outcome of the events heart rate high and oxygen saturation decreased were recovered on 28Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Pain, Paraesthesia, Pyrexia
Clinical narrative: Tingling sensation throughout body; Fever; Dizzy; Fatigue; Aches; This is a spontaneous report from a contactable other healthcare professional, the patient. A 71-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6208) via an unspecified route of administration in the right arm on 21Mar2021 at 09:15 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included vestibular neuronitis, hypertension and temporomandibular joint disorder (TMD). Concomitant medications included clonazepam (MANUFACTURER UNKNOWN), duloxetine (MANUFACTURER UNKNOWN) and amlodipine (MANUFACTURER UNKNOWN); all from an unknown date and for an unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6200) via an unspecified route of administration in the right arm on an unspecified date at 10:00, as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Mar2021 at 18:00, the patient experienced fever, dizzy, fatigue, tingling sensation throughout body and aches. The events resulted in doctor or other healthcare professional office/clinic visit. The patient contacted neurologist as a part of treatment for the reported events. The clinical outcome of the events fever, dizzy, fatigue, tingling sensation throughout body and aches were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity, Physical examination, Vaccination site pain, Vaccination site swelling
Clinical narrative: L Supraclavicular nodes x 2 (node #1 size of dime; node #2 size of penny); L arm soreness at injection site.; swelling at injection site.; tenderness at injection site.; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in left arm on 27Mar2021(at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history included DM2, HTN, Vitamin D deficiency, seasonal allergies, eczema, catfish/nickel allergies. Concomitant medications included lisinopril; hydrochlorothiazide (HCTZ) (MANUFACTURER UNKNOWN), cetirizine (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASA), metformin hydrochloride (METFORMIN ER), cholecalciferol (VITAMIN D3) for unknown indication from unknown date. The patient had known allergies to catfish and nickel. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021, the patient experienced L supraclavicular nodes x 2 (node #1 size of dime; node #2 size of penny); left arm soreness, swelling, tenderness at injection site. It was reported that nodes were still present at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events lymph nodes enlarged, left arm pain, vaccination site swelling and vaccination site pain was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise
Clinical narrative: mild expected side effects of slight headache; mild malaise; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8727) via unspecified route of administration in the right arm on 19Mar2021 at 13:30 (at the age of 66-year-old) as a single dose for Covid-19 immunisation. The patient's medical history included mild asthma, osteopenia, mild arthritis, long-lasting periods of fatigue and malaise following a brief viral illness with fever. Concomitant medication included estradiol cipionate (MANUFACTURER UNKNOWN) and ulmus rubra bark (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient had allergies to sulfa drugs (sulfonamide allergy). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6203), via an unspecified route of administration in the right arm on 25Feb2021 at 14:00 as a single dose for COVID-19 immunisation. . The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, it was reported that, after the 2nd shot, 22 hours later had mild expected side effects of slight headache, mild malaise and fatigue. Past after 36 hours, the patient felt fine for a day, then malaise and fatigue returned and have continued for 10 days up to 30Mar2021. The malaise had lessened in past couple of days or so, but moderate fatigue continued. The patient had felt worse after napping and in the morning. No treatment was received for the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of slight headache, mild malaise, and fatigue was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.